- Home
- LPCN vs INLF Comparison
LPCN vs INLF Comparison
Compare LPCN & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- INLF
- Stock Information
- Founded
- LPCN 1997
- INLF 2016
- Country
- LPCN United States
- INLF China
- Employees
- LPCN N/A
- INLF N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- INLF Industrial Machinery/Components
- Sector
- LPCN Health Care
- INLF Industrials
- Exchange
- LPCN Nasdaq
- INLF Nasdaq
- Market Cap
- LPCN 16.1M
- INLF 16.2M
- IPO Year
- LPCN N/A
- INLF 2025
- Fundamental
- Price
- LPCN $2.95
- INLF $1.12
- Analyst Decision
- LPCN Strong Buy
- INLF
- Analyst Count
- LPCN 2
- INLF 0
- Target Price
- LPCN $9.00
- INLF N/A
- AVG Volume (30 Days)
- LPCN 36.3K
- INLF 195.2K
- Earning Date
- LPCN 08-05-2025
- INLF 01-01-0001
- Dividend Yield
- LPCN N/A
- INLF N/A
- EPS Growth
- LPCN N/A
- INLF 18.78
- EPS
- LPCN N/A
- INLF 0.13
- Revenue
- LPCN $4,208,119.00
- INLF $15,796,983.00
- Revenue This Year
- LPCN N/A
- INLF N/A
- Revenue Next Year
- LPCN N/A
- INLF N/A
- P/E Ratio
- LPCN N/A
- INLF $8.71
- Revenue Growth
- LPCN N/A
- INLF 25.27
- 52 Week Low
- LPCN $2.68
- INLF $0.77
- 52 Week High
- LPCN $6.17
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- LPCN 37.54
- INLF N/A
- Support Level
- LPCN $2.92
- INLF N/A
- Resistance Level
- LPCN $3.25
- INLF N/A
- Average True Range (ATR)
- LPCN 0.19
- INLF 0.00
- MACD
- LPCN -0.04
- INLF 0.00
- Stochastic Oscillator
- LPCN 4.41
- INLF 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.